Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rosemina Merchant Insider Profile
4 Followers
Rosemina Merchant, Chief Development Officer at Medicenna Therapeutics Corp, holds 5.60M shares in Medicenna Therapeutics Corp (Ticker: TSE:MDNA).
Rosemina Merchant has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Rosemina Merchant's holdings
Insider Roles
Chief Development Officer
Roles that Rosemina Merchant holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 24, 2018 - Dec 24, 2019
Return:+289.10%
The most profitable trade made by Rosemina Merchant
Rosemina Merchant's Trading History
List of latest transactions for each holding click on a transaction to see Rosemina Merchant's performance on stock
You May Also Like
Rosemina Merchant insider profile FAQ
What is the percentage of profitable transactions made by Rosemina Merchant?
The percentage of profitable transactions made by Rosemina Merchant is ―.
What is the average return per transaction made by Rosemina Merchant?
The average return per transaction made by Rosemina Merchant is ―.
What stocks does Rosemina Merchant hold?
Rosemina Merchant holds: TSE:MDNA stocks.
What was Rosemina Merchant’s latest transaction?
Rosemina Merchant latest transaction was an Uninformative Sell of C$131.67K.
What was Rosemina Merchant's most profitable transaction?
Rosemina Merchant’s most profitable transaction was an Informative Buy of TSE:MDNA stock on December 24, 2018. The return on the trade was 289.10%.
What is Rosemina Merchant's role in Medicenna Therapeutics Corp?
Rosemina Merchant's role in Medicenna Therapeutics Corp is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.